TTWM
NVS icon

TCV Trust & Wealth Management’s Novartis NVS Stock Holding History

TCV Trust & Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,650
Closed -$267K – 192
2023
Q2 		$267K Sell
2,650
-1,729
-39% -$173K 0.03% 163
2023
Q1 		$403K Sell
4,379
-104,921
-96% -$9.16M 0.04% 147
2022
Q4 		$9.92M Buy
109,300
+387
+0.4% +$32.6K 1.13% 32
2022
Q3 		$8.28M Buy
108,913
+4,389
+4% +$364K 1.05% 38
2022
Q2 		$8.84M Buy
104,524
+4,439
+4% +$389K 1.06% 36
2022
Q1 		$8.78M Sell
100,085
-516
-0.5% -$44.7K 0.94% 40
2021
Q4 		$8.8M Sell
100,601
-2,034
-2% -$169K 0.88% 43
2021
Q3 		$8.39M Buy
102,635
+1,405
+1% +$126K 0.93% 42
2021
Q2 		$9.3M Buy
101,230
+3,159
+3% +$281K 1.02% 41
2021
Q1 		$8.38M Buy
98,071
+764
+0.8% +$68.6K 0.97% 41
2020
Q4 		$9.19M Buy
97,307
+1,558
+2% +$136K 1.11% 36
2020
Q3 		$8.33M Buy
95,749
+1,608
+2% +$139K 1.12% 35
2020
Q2 		$8.22M Buy
94,141
+3,814
+4% +$329K 1.17% 36
2020
Q1 		$7.45M Buy
90,327
+1,673
+2% +$149K 1.22% 33
2019
Q4 		$8.39M Buy
+88,654
New +$7.95M 1.02% 37

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCV Trust & Wealth Management's NVS Position: Q3 2023 in Review

TCV Trust & Wealth Management sold out of Novartis (NVS) in Q3 2023, closing a stake of 2,650 shares — an estimated $267K sold.

TCV Trust & Wealth Management first reported a position in NVS in Q4 2019 and held it in 15 quarters. The position peaked at $9.92M in Q4 2022. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

  • TCV Trust & Wealth Management reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
  • TCV Trust & Wealth Management sold 2,650 Novartis shares in Q3 2023, an estimated $267K.
  • TCV Trust & Wealth Management first reported a position in Novartis in Q4 2019 and held it in 15 quarters.
  • TCV Trust & Wealth Management's Novartis position peaked at $9.92M in Q4 2022.
  • 1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2023, filed 19 Oct 2023.